680Indexed trials
canonical disease area
Alzheimer's Disease
Intelligence
Alzheimer's Disease intelligence: 680 indexed trials, 146 recruiting studies, 414 sponsors across 59 countries.
146Recruiting
414Sponsors
59Countries
Leading sponsors
Massachusetts General Hospital123 recruiting
Avid Radiopharmaceuticals120 recruiting
Eli Lilly and Company92 recruiting
Hoffmann-La Roche81 recruiting
Johns Hopkins University84 recruiting
University of California, Los Angeles82 recruiting
Emory University71 recruiting
Pfizer70 recruiting
Merck Sharp & Dohme LLC71 recruiting
National Institute on Aging (NIA)71 recruiting
Novartis60 recruiting
Janssen Research & Development, LLC60 recruiting
Geographic activity
United States337trials
France89trials
Canada71trials
United Kingdom56trials
Spain50trials
Italy44trials
Germany41trials
Australia37trials
Sweden36trials
Japan33trials
China31trials
South Korea31trials
Leading interventions
Donepezil12trials
florbetapir F 186trials
Memantine6trials
Flortaucipir F184trials
Lecanemab4trials
Gantenerumab4trials
Donanemab4trials
MRI4trials
Crenezumab3trials
Bryostatin 13trials
CAD1063trials
Magnetic Resonance Imaging (MRI)3trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.